H7N9 claims more lives in China

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 20 Feb, 2014

Singapore: Hong Kong's Centre for Health Protection (CHP) and the provincial health department have reported eight new human cases of H7N9 Avian Influenza in four Chinese provinces. The de...Read more

Vaccines do not cause autism: Study

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 30 May, 2014

Singapore: Researchers from the University of Sydney, have dismissed any link between development of autism and childhood vaccination programs. In a study that covered more than 1.25 milli...Read more

EU join hands to develop personalized cancer vaccines

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: Europe has established Glioma Actively Personalized Vaccine Consortium, (GAPVAC), a project designed to create, manufacture and develop actively personalized vaccines (APVACs) to...Read more

Focus on needs of society: Dr Weidong Yin

Vaccines |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2012

Dr Weidong Yin, the man behind Sinovac, was honoured with BioSpectrum Asia Pacific Bioscience Industry Entrepreneur of the Year Award for 2011. Sinovac was established in 2001 with a missio...Read more

Panacea gets govt order worth $34 million

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 17 Dec, 2012

New Delhi: India's second largest producer of vaccines, New Delhi-based Panacea Biotec, has received a government order worth $34 million (Rs 187.61 crore) for the supply of 345 million dos...Read more

Emergent to market VaxInnate flu vaccine

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 31 Dec, 2012

Singapore: Emergent BioSolutions has signed a license agreement with VaxInnate under which Emergent acquired the exclusive right to manufacture and sell VaxInnate's pandemic influenza vacci...Read more

WHO: Bird flu is back in China

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2013

Singapore: Three cases of human infection with influenza A (H7N9) has erupted in China, notified China Health and Family Planning Commission to World Health Organization (WHO). The cases we...Read more

FDA approves Flucelvax, a cell-culture vaccine against seasonal influenza

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: US Food and Drug Administration (FDA) has approved Flucelvax (Influenza Virus Vaccine), the first cell-culture-derived vaccine, for individuals 18 years of age and older. Develo...Read more

Takeda acquires LigoCyte Pharmaceuticals at $60 mn

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: LEO Pharma plans to establish five long-term, strategic research collaborations in four countries by the end of next year. The ambitious initiative aims to deliver new treatment ...Read more

FDA approves GSK's combo meingitis vaccine

Vaccines |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2012

Singapore: The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's vaccine MenHibrix (Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine). Men...Read more

Biodiem gets US patent allowance for antifungal therapy

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: Australian infectious disease therapy and vaccine development company BioDiem has received notice of Allowance of a new US divisional patent from US Patent and Trademark Office, ...Read more

Arterial Remodeling Technologies receives regulatory approval

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

  Australian vaccine development company BioDiem Ltd has announced that it has begun research collaboration with France-based VIVALIS, a biopharmaceutical company with expertise in vaccin...Read more

'China's H7N9 outbreak an epidemic'

Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 17 Mar, 2014

Singapore: While experts and health ministries in various Chinese provinces have declared the on-going second wave of H7N9 in the country as more destructive than the first one in early 201...Read more

MR vaccine drive for all

Vaccines |  News | 0 Comment | 13 Apr, 2017

To quell the rumours around the measles-rubella vaccine, UNICEF has reached out to Islamic civil society organisations, religious leaders and academia to create trust and address myths arou...Read more

Globally Zika Virus vaccines market expected to reach $18,697 mn by 2022

Vaccines |  News | 0 Comment | 04 Jan, 2017

A new report published by Allied Market Research, titled, “Potential Market for Zika Virus Vaccines: Global Opportunity Analysis and Industry Forecast, 2017–2022”, project...Read more

CEPI board meeting with a focus on identifying disease priorities and future strategy

Vaccines |  News | 0 Comment | 19 Dec, 2016

The Department of Biotechnology (DBT) will be partnering in the Coalition for Epidemic Preparedness and Innovations (CEPI) which is a new global alliance among governments, industries, acad...Read more